Reported to the IN Attorney General on April 17, 2026.
IN residents may qualify for compensation. Free attorney review — no obligation, no upfront cost.
Check My Rights →Sagent Pharmaceuticals was the subject of a data breach notification filed with the IN Attorney General. The AG filing was recorded on April 17, 2026. The breach or discovery date reported in the filing is February 11, 2026.
Sagent Pharmaceuticals operates as a prominent developer, manufacturer, and distributor of specialty pharmaceuticals and injectable medications used extensively within hospital and clinical settings across the United States. Because of its core role in the healthcare supply chain, the enterprise routinely handles intricate networks of sensitive data. This encompasses extensive employee personnel files, payroll and compensation records, proprietary corporate data, and potentially confidential patient or clinical trial participant information gathered through research partnerships and healthcare delivery channels. The sheer volume of personally identifiable information (PII) and protected health information (PHI) processed across its administrative and operational networks makes the company an attractive target for malicious cyber actors. In 2026, Sagent Pharmaceuticals formally reported a significant data security incident to the Indiana Attorney General, alerting regulators and affected individuals to an unauthorized compromise of its network systems. While the exact vector of the breach remains subject to ongoing forensic investigation, security incidents affecting major pharmaceutical and healthcare supply entities typically involve sophisticated ransomware deployments, third-party vendor compromises, or unauthorized intrusion into corporate databases. In attacks of this nature, unauthorized threat actors frequently exploit vulnerabilities in perimeter defenses or compromise employee credentials to infiltrate internal servers, potentially exfiltrating vast archives of confidential corporate and personal data before detection. The exposure of sensitive records in a pharmaceutical data breach carries severe, long-term ramifications for every affected individual. When data types such as full names, dates of birth, Social Security numbers, banking details, and health-related information are compromised, victims face an elevated risk of identity theft, medical fraud, and targeted financial scams. Unlike transient inconveniences, leaked Social Security numbers and birth dates cannot be easily reset, leaving victims vulnerable to fraudulent credit applications, tax fraud, and unauthorized medical procedures billed under their identities. Furthermore, the compromise of employee compensation and payroll records exposes staff to targeted spear-phishing and account takeover schemes. Operating within the pharmaceutical and healthcare sectors, Sagent Pharmaceuticals is bound by stringent federal and state legal frameworks, including the Health Insurance Portability and Accountability Act (HIPAA), the Federal Trade Commission Act, and state-level data breach notification statutes. These laws mandate the implementation of rigorous administrative, physical, and technical safeguards to secure sensitive personal and health information against unauthorized access. A breach of this magnitude strongly indicates potential systemic failures in maintaining adequate cybersecurity measures, failing to encrypt sensitive databases, or neglecting to properly vet third-party vendor access points, all of which may constitute actionable negligence under the law. Receiving an official data breach notification letter from Sagent Pharmaceuticals is a formal acknowledgment that your private information was compromised due to inadequate corporate security practices. Legally, this notification confirms your standing to participate in a class action lawsuit aimed at holding the company accountable for failing to safeguard your data. Under modern data privacy jurisprudence, victims do not need to wait until financial fraud has actually occurred to seek legal recourse; the increased risk of future identity theft constitutes a legally cognizable injury. Our firm is currently investigating potential class action claims on a contingency fee basis, meaning there are never any out-of-pocket costs or fees unless we successfully recover compensation on your behalf.
Based on the data types reported in this filing, affected individuals face the following specific risks:
Your SSN is the master key to your identity. Once exposed, criminals can open new lines of credit, take out loans, or file taxes in your name.
Combined with a name and other leaked data, date of birth helps criminals pass identity verification questions at banks and government agencies.
Under the Indiana data breach notification law, you may have a legal claim against Sagent Pharmaceuticals if any of the following apply:
Applicable law: This breach was reported under the Indiana data breach notification law, which establishes your right to seek damages from Sagent Pharmaceuticals.
The hours spent responding to a data breach — canceling accounts, contacting credit bureaus, updating passwords, and investigating fraud — represent compensable economic harm in data breach litigation.
Once your SSN is exposed, protection becomes an ongoing expense. Plaintiffs in data breach settlements have recovered costs for credit freezes, identity protection subscriptions, and time spent dealing with fraudulent accounts — sometimes covering multiple years of exposure.
HIPAA violations carry civil penalties between $100 and $50,000 per violation. Where a healthcare organization's negligence led to the exposure of protected health information, class members may recover statutory damages in addition to actual losses.
Fees charged to close and reopen accounts, issue replacement cards, or dispute fraudulent transactions are recoverable in data breach litigation. So are the costs of overdrafts, late payments, and credit damage caused by unauthorized activity.
Data breach victims regularly report anxiety, loss of sleep, and ongoing fear of identity theft. These non-economic harms are cognizable injuries in data breach litigation, particularly in cases involving SSN or medical record exposure.
Note: an attorney general breach filing does not by itself establish a settlement fund, a payment amount, or a claim deadline. If an official settlement notice is later issued, rely on that notice for payment details and deadlines.
No. Under Indiana data breach notification law and federal law, the unauthorized exposure of your personal data — regardless of whether it has been actively misused — can be sufficient grounds for a claim. The breach itself is the injury.
Nothing. The Law Office of David S. Harris handles data breach cases on contingency — you pay zero upfront and owe nothing unless compensation is recovered.
Immediately place a free credit freeze at all three bureaus (Equifax, Experian, TransUnion). A freeze blocks new accounts from being opened in your name. Then file a complaint with the FTC at IdentityTheft.gov and contact our office — SSN exposure is one of the most serious breach types.
If Sagent Pharmaceuticals is a covered healthcare entity or business associate under HIPAA, affected patients have additional rights — including the right to an HHS complaint. These HIPAA violations also strengthen civil damages claims. Consult an attorney to understand your full remedies.
Banks may reverse fraudulent charges, but they are not obligated to compensate you for time lost, stress, or indirect damages. A class action claim against the breached company can recover those additional categories of harm.
State statutes of limitations for data breach claims typically run 2–4 years from the date of the breach or its discovery. Because this breach was recently disclosed, the window is open — but acting early preserves your options and strengthens the case.
Accepting free credit monitoring from Sagent Pharmaceuticals does not waive your right to pursue legal action unless you signed a specific release waiving claims. In most cases, victims who accepted monitoring can still file.
Received a notification letter from Sagent Pharmaceuticals?
Read our dedicated guide — what the letter means and exactly what to do.
If you were affected by the Sagent Pharmaceuticals data breach, you may be entitled to compensation. Submit your information below for a free attorney review — no obligation, no upfront cost.
Source: State Attorney General filing, IN
View Official AG Filing →Sagent Pharmaceuticals breach?
Free case review · No fee unless you win